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Caffeine is the most widely used psychoactive stimulant with prevalent use across all
age groups. It is a naturally occurring substance found in the coffee bean, tea leaf, the
kola nut, cocoa bean. Recently there has been an increase in energy drink consumption
leading to caffeine abuse, with aggressive marketing and poor awareness on the conse-
quences of high caffeine use. With caffeine consumption being so common, it is vital to
know the impact caffeine has on the body, as its effects can inﬂuence cardio-respiratory,
endocrine, and perhaps most importantly neurological systems. Detrimental effects have
being described especially since an over consumption of caffeine has being noted. This
review focuses on the neurophysiological impact of caffeine and its biochemical pathways
in the human body.
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INTRODUCTION
In today’s fast-paced lives people need vigor to keep up with their
demanding schedules and lifestyles. Often, they need some assis-
tance in doing so. Caffeine is a naturally occurring chemical and is
referred to as an“ancient wonder drug” (McCarthy et al., 2008) for
its potential to revive weary workaholics. It was discovered in the
coffee bean (Coffea arabica) in Arabia, the tea leaf (Thea sinensis)
in China, the kola nut (Cola nitida) in West Africa, and the cocoa
bean (Theobroma cacao) in Mexico (Chou, 1992). Caffeine prod-
ucts are sowidely distributed these days that abuse of the substance
may be unnoticed. In fact, caffeine is the world’s most widely con-
sumed stimulant, with 54% of adults in America consuming on
average three cups of coffee a day (Chen and Parrish, 2008). Aside
from occurring organically in tea and coffee, caffeine is now an
additive in soft drinks, energy drinks, chocolates, bottled water,
chewing gum, and medication (Mednick et al., 2008). The aim of
this paper is to elicit an awareness of the neurophysiological effects
of caffeine. This article emphasizes caffeine’s potential effects on
the nervous system within the context of increased caffeinated
energy drink consumption around the world.
CAFFEINE CONSUMPTION
Aside from being added to beverages, caffeine is now being added
to food products such as potato chips, chocolates, and bottled
water,which conﬁrms its growingpopularity (Temple,2009). Since
the introduction of Red Bull in 1987, the energy drink market has
grown extensively, with hundreds of different brands of varying
caffeine content now available (Reissig et al., 2009).
There has been an increase in reports of caffeine-intoxication
since 1982, with 41 cases of caffeine abuse reported in the United
States from 2002 to 2004 (Reissig et al., 2009). This could be an
indicator of an increase in caffeine dependence and withdrawal
symptoms (Reissig et al., 2009).
European and North American statistics report that 90% of
adults consume caffeine on a daily basis, with an average intake
of 227mg (Reissig et al., 2009; Temple, 2009). The South African
Food Based Dietary guidelines recommend that adults limit their
daily intake of caffeine drinks to no more than four cups of coffee
per day or eight cups of tea per day, which is in line with the US
Food and Drug Administration reporting a moderate caffeine use
as safe (a moderate daily dose being 300mg and below and high
daily doses being 500–2000mg1; Temple, 2009). Unfortunately,
the statistics on South African consumptions are not readily avail-
able2, so European and North American statistics are described
instead: The top three sources of caffeine are coffee (70%), cold
drinks (16%), and tea (12%) in the United States. Table 1 shows
the caffeine content in some popular dietary sources.
From Table 1 it is clear that brewed coffee has almost three
times the amount of caffeine as instant. Energy drinks have twice
the amount of caffeine as regular cold drinks andwith ever increas-
ing consumption, this constrains us to be informed about the
neurological consequences this could have.
BIOCHEMICAL CHARACTERISTICS
Caffeine has a chemical structure of is 1,3,7-trimethylxanthine
(Figure 1). Methylxanthine has a similar structure to purines,
adenosine, xanthine, and uric acid (Chou, 1992).
In nature, caffeine is found in a diversity of plants, kola nuts,
cherries, and cocoa beans and is presumed to offer protection
to plants by acting as an anti-herbivory and allelopathic agent
(Chen et al., 2008). In humans, caffeine is quickly absorbed by
the gastrointestinal tract. Caffeine from coffee is absorbed faster
than caffeine from cold drinks. Some reasons for this could be:
the lower temperature of the beverage may decrease the rate of
1http://www.fda.gov/Food/FoodIngredientsPackaging/FoodAdditives/FoodAdditi
veListings/ucm091048.htm [accessed August 31, 2011]
2http://sun025.sun.ac.za/portal/page/portal/Health_Sciences/English/Centres%20
and%20Institutions/Nicus/NutritionFactssheets/Beverage%20Consumption.pdf-
beverageconsumption [accessed August 31, 2011]
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Table 1 |Types of food and drink caffeine content (Jones and
Fernyhough, 2008).
Item Caffeine content (mg)
Tea (227ml)
Weak 25
Medium 42
Strong 51
Coffee (227ml)
Instant 45
Brewed 111
Cola-drinks (330ml) 35
Red Bull (240ml) 80
Milk chocolate (solid) (9 g) 6
Dark chocolate (solid) (9 g) 20
FIGURE 1 | Chemical structure of caffeine (Deng et al., 2008).
blood ﬂow within the intestines; phosphoric acid in cold drinks
could decrease gastric emptying; absorption rate could increase
with caffeine dose; sugar in cold drinks could inhibit gastric emp-
tying of caffeine and delay absorption (Ligouri et al., 1997). In
fact, 99% of the orally ingested chemical is taken up within 45min
(Chou, 1992).
Caffeine disperses throughout the body and penetrates the bio-
logical membranes, the blood brain barrier and placenta, however
it does not accumulate in the tissues or organs (Chou, 1992;
Temple, 2009). Just 15–20min after oral ingestion, peak plasma
concentration is reached. The half-life in adult males is decreased
by 30–50% in smokers and is doubled in women taking oral
contraceptives and extended further in the last trimester of preg-
nancy and in patients with chronic liver disease (Chou, 1992). This
means that there is increased caffeine metabolism in conjunction
with cigarets while oral contraceptives, pregnancy, and chronic
liver disease delay metabolism of caffeine in the body. This can
be accounted for by examining caffeine’s metabolism which is
species-speciﬁc. In Camellia (tea) species caffeine is degraded via
theophylline into primary metabolites. In coffea (coffee) species
caffeine is also degraded via theophylline but through a different
route (Ashihara et al., 2008). Caffeine is converted into dimethylx-
anthines, dimethyl and monomethyl uric acids, trimethyl and
dimethyl-allantoin and uracil derivatives in the liver. Only 2–3%
of caffeine is excreted in urine unchanged (Chou, 1992; Nehlig,
1998). While caffeine itself is eliminated overnight from the body,
some primary metabolites such as theobromine and theophylline
have longer half-lives.
Caffeine and its primary metabolites, theobromine, paraxan-
thine, and theophylline are identiﬁed in all body ﬂuids (Grosso
and Bracken, 2005). Paraxanthine levels decrease less rapidly than
caffeine and are further metabolized via two independent reac-
tions. These paraxanthine metabolites are found in urine (Grosso
and Bracken, 2005). Theobromine makes up the largest part of
caffeine metabolites, with only 50% excreted in urine. Some of the
effects of caffeine in systems other than the nervous system are
described.
CARDIOVASCULAR AND RESPIRATORY EFFECTS
Caffeine induces various acute cardiovascular effects such as an
up regulation of circulating catecholamines. Arterial stiffness
and endothelium dependent vasodilatation also result, leading to
increases in systolic and diastolic blood pressure (DBP; Riksen
et al., 2009). An increase in the respiration rate (RR) is the prime
effect dependent on the plasma caffeine value (Chou, 1992).
ENDOCRINE AND METABOLIC EFFECTS
Caffeine enhances circulating catecholamine levels. Owing to this
mechanism there is an increase in the basal metabolic rate – this
includes lipolysis which releases free fatty acids (Chou, 1992).
GASTROINTESTINAL AND URINARY EFFECTS
Caffeine excites the small intestine, causing secretion of water
and sodium (Chou, 1992). Its pharmacological effects include
diuresis.
From a medical view, caffeine has been seen to promote apop-
tosis in UVB-damaged cells, to antagonize adenosine receptors
for regulating contraction of blood vessels and even serves as a
psychoactive drug in the treatment of Parkinson’s disease (Chen
et al., 2008). With its potential utilization in medicine, the safety
and effects of caffeine are important issues.
BENEFITS OF CAFFEINE TO THE HUMAN BODY
Unfortunately, a reviewof the literature shows two important limi-
tations in caffeine research. Firstly, research on animals uses doses
that are hundreds to thousands of times higher than those seen
in human consumption. Therefore, relating the results to humans
becomes difﬁcult (Chou, 1992). Secondly, some studies investigate
pure caffeine, while others pose research questions pertaining to
coffee, not pointing out the other components in coffee and their
potential confounding effects (Chou, 1992).
Despite these limitations, extensive explorations of caffeine
have been carried out and have provided a great deal of informa-
tion regarding the effects of caffeine. Under the next few headings
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the major neurophysiologic effects of caffeine are discussed as the
main focus of this article.
AROUSAL AND FATIGUE
Arousal is considered to be a variable state reﬂecting the present
energetic factors and task-related activation, the degree of “aware-
ness”an individual has and inneuropsychology context an increase
in arousal relates to a better ability to carry out a task (Barry
et al., 2005). There is an apparent link between caffeine effects and
dopamine functions. This evidence does not preclude the involve-
ment of other neuromodulator systems, though. In fact, it has
been reported that caffeine increases the ﬁring rates in mesopon-
tine cholinergic neurons, which participate in the production of
arousal (Lorist and Tops, 2003). These cholinergic neurons are
inhibited by adenosine,providing a couplingmechanism that links
arousal and caffeine, yielding proof for the role of caffeine in the
behavioral state of arousal (Lorist and Tops, 2003).
A study conducted by Barry et al. (2008) proves that caf-
feine does increase arousal by increasing skin conductance level
(SCL), while decreasing heart rate (HR) and decreasing levels of
DBP. Arousal effects from caffeine were noted in a 30-min period
approximately 25min after ingestion. An increase in RR was noted
to peak at 33min and then decreasewith time. The subjects carried
out two tasks – an auditory task composed of an active audi-
tory oddball task and a visual task requiring the subjects to focus
their vision on a speciﬁc spot without excessive blinking. Barry
et al. (2008) suggest that caffeine produced a reduction in reac-
tion time in the tasks carried out, supporting the idea that blood
pressure effects reﬂect effortful task-related activity rather than
arousal changes. Caffeine produced an increase in SCL levels and
a reduction in alpha power. Alpha generators are unchanged by
caffeine and therefore caffeine causes arousal without manipu-
lating task requirements, consistent with caffeine’s antagonistic
effects on adenosine receptors reducing inhibition of cholinergic
neurons. Post-task effects of caffeine included changes in blood
pressure activity and alpha and beta power implying that caffeine
may have effects on task performance above arousal effects (Barry
et al., 2008). Caffeine also has beneﬁcial effects on choice reaction
time, especially in the elderly with a daily dosage of 200–400mg
(Smith, 2002).
It is noted that caffeine can affect the attention system. Atten-
tion can alter the neural activity in cortical areas that may intensify
the responsivity of cells to speciﬁc stimulus features (Lorist and
Tops, 2003). A substantial number of studies show that caffeine
consumption increases alertness anddecreases fatigue (Barry et al.,
2008; Smith, 2002; Biggs et al., 2007; Kennedy et al., 2008) in large
and moderate doses.
To evaluate the effect of caffeine on sleep deprivation and dri-
ving Biggs et al. (2007) conducted a study using 12 regular drivers
that are non-smokers, with healthy BMIs, between the ages of 20
and 30 years. Coffee and placebo were administered, with every
subject acting as his/her own control. Caffeine was shown to
have a beneﬁcial effect on all driving tests and the data suggests
that caffeine returned driving performance to baseline (pre-sleep
deprivation) levels (Kennedy et al., 2008); thereby proving that
caffeine does increase alertness and can be beneﬁcial in driving
tasks.
PERCEPTUAL PROCESSING
Perception is a process of gaining some formof knowledge through
thought, experience, and the senses (Wang, 2009). Lorist and Tops
(2003) used a task consisting of a stimulus quality which was
manipulated. The non-degraded stimulus consisted of a dot pat-
tern surrounded by a rectangular frame of dots (see Figure 2). In
the degraded condition dots were placed from the frame into vari-
able positions. This new arrangement impaired the identiﬁcation
of the stimulus. Caffeine increased the ability to process degraded
stimuli (see Figure 3; Lorist and Tops, 2003). By contrast, Smith
(2002) conducted a perceptual task requiring participants to dis-
criminate between two targets per trial. The group that received
caffeine showed no signiﬁcant difference in the perceptual task
compared to those that did not receive caffeine. Another study
conducted by Ruijter et al. (2000) tested the effect of caffeine on
sustained attention required by subjects to work continuously for
10min in a self-paced task. The task consisted of a color selection
task, a spatial selection task, and a concentration task. Subjects
were administered a moderate dose of 250mg of caffeine. The
results showed an increase in arousal but no change in percep-
tual behavior. From this we can see that the effect of caffeine on
perception is inconsistent.
FIGURE 2 | Non-degraded stimulus.
FIGURE 3 | Degraded stimulus.
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MOTOR BEHAVIOR
Motor skill learning is one of themain functions of the central ner-
vous system. It is a process of increasing the spatial and temporal
accuracy of movements with practice. Motor skill has two promi-
nent learning phases: an initial fast learning phase and later, slow
learning phase (Xiong et al., 2009). In the early stage of learning
a great deal of improvement in performance is attainable within a
few minutes. Precise knowledge of the movement is used to pro-
mote the control and co-ordinationof speciﬁc body action.During
the later phase, there is slow learning progress and less attention
is needed to perform the task. The prefrontal cortex is responsible
for movement in the parts of the body, it also guides eye and head
co-ordination (Xiong et al., 2009).
Dopamine is a neurotransmitter with excitatory and inhibitory
effects. Neurons of the substantia nigra have nerve endings in
the caudate nucleus and putamen of the cerebrum, where they
release dopamine. Dopamine acts as an inhibitor in the basal gan-
glia and is excitatory in other areas of the brain (Xiong et al.,
2009).U-shaped dose–response curves in humans show that either
too much or too little dopamine results in diminished prefrontal
cortex functioning.
The mesocorticolimbic dopaminergic system mediates
approachmotivation. Dopamine receptorsD2 regulate neural net-
works that are involved in selective and involuntary attention
(Lorist and Tops, 2003). Caffeine increases behavior related to
dopamine by inhibiting adenosine A2A receptors and increasing
transmission via dopamine D2 receptors (Lorist and Tops, 2003).
Lorist and Tops (2003) used an echoencephalograph (EEG) to
highlight the alpha brain wavelength (alpha power). They found
that caffeine intake increased left frontal activation compared to
the right, suggesting that dopamine function could be linked to
fatigue, with caffeine reducing fatigue.
Mednick et al. (2008), conducted a study was composed of 61
adults 18–39 years old that were given a motor task requiring them
to ﬁnger tap a 4-1-3-2-4 sequence on a keyboard with the non-
dominant hand. The caffeine group showed signiﬁcantly impaired
motor learning.
LEARNING AND MEMORY
Learning is the acquisition of new information by the nervous
system, resulting in changes in behavior or“analytical-speciﬁc per-
ceptual skills” (Mangina and Sokolov, 2006). Memory is the ability
to store, process, and recall learnt information. Modality-non-
speciﬁc memory is associated with the limbic system, especially
the hippocampus (Mangina and Sokolov, 2006). Neurons in the
hippocampus contribute to the formations of declarative mem-
ory units. These neurons can be trained to memorize perceptual
images and these “trained”neurons are then arranged in a column
in accordance to their learning sequence (Mangina and Sokolov,
2006).
Long-term potentiation (LTP) is a major candidate for the
neurophysiological basis of learning andmemory. TheLTPmecha-
nism seems to be dependent on activity of glutamatergic receptors
and N -methyl d-aspartate (NMDA) receptors are required for
induction of LTP while expression of LTP involves α-amino-3-
hydorxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
Gamma-aminobutyric acid (GABA) receptors also seem to be
involved in the mechanisms of LTP, along with other neurotrans-
mitters such as acetylcholine, dopamine, serotonin, and norep-
inephrine (Myhrer, 2003) Dopamine has an impact on perfor-
mances, motivational processes, and procedural memory, while
acetylcholine interacts with dopamine in cognitive functions
and with serotonin acts in cognitive behavior, to a lesser extent
serotonin and norepinephrine have a weaker inﬂuence.
The results from a perceptual learning task and a motor task
according to Smith (2002) may be explained by the relative level of
explicit information involved in learning. The perceptual learning
task requires the least explicit material, while the motor task shows
a strong explicit component. The information shows that caffeine
may help in some tasks but impair others. This may be because
caffeine increases alertness and decreases fatigue, causing a better
performance in some tasks (Smith, 2002).
There is concern regarding strategies that can improve the
elderly quality of life regarding the diminished cognitive and
motor functions that occur with aging (Costa et al., 2008). In a
study conducted by Costa et al. (2008) it is stated that the caffeine
administered in adult mice prevented age-associated decline in
recognition memory when evaluated 90min after training (corre-
sponding to short term memory). There is however, the possibility
of anxiety being elicited, due to high caffeine doses.
STRESS AND ADDICTION
Stress can be deﬁned to when the human body is not able to cope
suitably to physical or emotional threats. The brain is the major
component of interpreting and responding to potentially stressful
events and determines what is stressful. It is also the central organ
of the behavioral and physiological response to stressors and is also
a target for the actions of stress hormones such as glucocorticoids
(Ferreira et al., 2004).
Studies show that during periods of increased stress, caffeine
consumption increases (Yeomans et al., 2007). Caffeine increases
cortisol secretion by stimulating the central nervous system so it is
advisable to individuals with hypertension to avoid caffeine during
periods of stress as this further increases blood pressure (Yeomans
et al., 2007; Dack and Reed, 2009). Chronic caffeine consumption
causes sensitization of a speciﬁc subset of cannabinoid receptors
in the striatum, consistent with the psychoactive properties of the
compound (Sheperd et al., 2000; Herrick et al., 2009). This may
explain why enhanced relaxation and a sense of well being are
some of the reported effects of caffeine use during stressful events.
Caffeine mechanism action can be explained as follows.
With regular average doses of caffeine in humans, caffeine
acts as an antagonist of the adenosine receptors and exhibits an
equal afﬁnity for A1 and A2A receptors. However when acutely
administered caffeine acts dominantly on A1 receptors (as ambi-
ent adenosine activates it). Chronic caffeine consumption causes
tolerances of the A1 receptors, caffeine then has negligible effects
onA1 receptor and dominant effects onA2A receptors (Rossi et al.,
2010).
The endocannabinoid, endogenous ligands of the cannabi-
noids receptors are synthesized when needed, in response to the
increased neuronal excitation and activates the presynaptic CB1
receptor, decreases the levels of cyclic AMP (cAMP) released and
decreases neurotransmitter release (Rossi et al., 2010). Caffeine
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increases neurotransmitter release by removing inhibitory control
for acetylcholine in the hippocampus and prefrontal cortex, regu-
lating the opening of potassium channels which is mediated by A1
receptors, increasing the ﬁring rate of neurons (Rossi et al., 2010).
A2A receptor striatum dendrite spines, here they inhibit
Glutamatergic-thalamo-cortical neurons by inducing cell activa-
tion and stimulating adenylate cyclase pathway. Caffeine blocks
A2A receptors and decreases stimulatory actions on cAMP induced
by adenosine (Rossi et al., 2010).
The striatum is the main receiving area of the basal ganglia,
consisting mainly of GABAergic neurons that receive excitatory
input from the cortex, inhibitory input from the axon collaterals
and striatal interneurons, and modulatory input from the mid-
brain dopaminergic neurons. Impacts of these inputs control the
outputs to the substantia nigra and globus pallidus and play a role
on the effect caffeine has on the striatal neurotransmission (Rossi
et al., 2010).
Caffeine can reduce the inhibition on striatal dopamine trans-
mission reducing the activity of striatal neurons and causing
thalamo-cortical projections neurons to disinhibit. The activa-
tion of A2A receptors results in cAMP production, activation of
D2 receptors decreases the production of cAMP causes a reverse
regulation of the activity of cAMP-dependant protein kinase
(PKA; Rossi et al., 2010). Since caffeine mimics the dopamine
action on the striatopallidal neurons, it causes a progressive sen-
sitization of cannabinoid CB1 receptors controlling GABergic
inhibitory postsynaptic currents (IPSCs; Herrick et al., 2009).
Caffeine blocking the A2A receptors reduces the activation of
cAMP–PKA pathways causing an increase in glutamate release,
activation of metabotropic mGlu5 receptors, and endocannabi-
noid release (Rossi et al., 2010). The blockade of adenosine A2A
receptors in the striatum, has been associated with the psychoac-
tive properties of caffeine. Also, evidence shows that a speciﬁc
genetic polymorphism of the adenosine A2A receptor inﬂuences
the habitual caffeine consumption in humans (Herrick et al.,
2009).
Evidence has also shown that caffeine induces striatal synaptic
adaptations anddoes not alter the sensitivity of glutamate synapses
toCB1 receptor stimulation inmice,displaying the existenceof dif-
ferential regulation mechanisms of distinct cannabinoid receptors
in the striatum (Rossi et al., 2010). The caffeine induced adapta-
tion of the endocannabinoid in mice was reversible and after drug
withdrawal, symptoms were reversed with a decline in 15 days and
totally reversed in 30 days.
Caffeine induced alteration of cannabinoid transmission may
have synaptic consequences during the physiological activity of
the striatum since chronic caffeine has been shown to enhance the
sensitivity of the GABergic synapses to synthetic cannabinoid CB1
receptors agonist and the endocannabinoids,mobilized to respond
to the stimulation of metabotropic receptors (Rossi et al., 2010). A
study on mice shows at toxic levels, caffeine causes calcium release
from intracellular space, inhibition of phosphodiesterase, GABBA
receptor antagonism, protein kinase C activity (Rossi et al., 2010).
It is likely that caffeine effects in humans are more complicated
than it is in animal studies.
Evidence exists that cannabinoid receptors are implicated in the
mechanismof actionof psychoactive drugs and stress, so enhanced
activity of the cannabinoid CB1 receptors plays a role in the
rewarding effects of morphine, heroin, cocaine, ethanol, amphet-
amine, and nicotine (Herrick et al., 2009). Caffeine induced alter-
ations of cannabinoid transmission may have relevant outcomes
during the physiological activity of the striatum. Caffeine effects
on the striatal cannabinoid system were similar to those of cocaine
(such as the enhanced synaptic defects prompted by stress). It also
has been reported that caffeine and cocaine have additive prop-
erties and caffeine reinforces cocaine-seeking behavior following
elimination of cocaine self-administration (Herrick et al., 2009).
THE DISADVANTAGES OF CAFFEINE TO THE HUMAN BODY
As previously stated, caffeine could have detrimental effects on a
hypertensive that is stressed and consumes caffeine as ultimately
caffeine is a stimulant and as with as all stimulants and substance’s
abuse or overuse has negative effects. This review looks at some of
the detriments of caffeine on the nervous system.
DEFICITS IN LEARNING
Multiple doses of caffeine are consumed in individuals suffering
from insomnia to reduce fatigue and increase alertness (Med-
nick et al., 2008). However caffeine may have negative effects on
cognition in general and perceptual memory and learning in par-
ticular (Mednick et al., 2008). The study by Mednick et al. (2008)
shows a comparison of a nap and caffeine on verbal, motor, and
perceptual memory. Caffeine causes an increase in hippocampal
acetylcholine. This may block consolidation by congesting replay
of memories. A moderate dosage of caffeine impairs motor skill
and may not be an adequate substitute for memory enhancements
or daytime sleep (Mednick et al., 2008).
Neurogenesis is the growth and development of the nervous tis-
sue. Neurogenesis occurs in the hippocampal and olfactory bulbs
until adulthood (Guyton andHall, 2006;Wentz andMagavi,2009).
A study conducted by Wentz and Magavi (2009) showed that
administering high doses of caffeine (20–30mg/ml) to adult mice
inﬂuenced the proliferation of hippocampal neural precursors in
a duration-dependent dose. This negatively inﬂuenced the neural
circuits into which adult-born neurons are integrated (Wentz
and Magavi, 2009). Caffeine can therefore depress hippocampal
neurogenesis.
ANXIETY AND PANIC ATTACKS
When a single dose of 300mg is administered, caffeine can
increase anxiety and tension. Meanwhile a 400-mg dose of caf-
feine increases anxiety when paired with a stressful task (Smith,
2002). In general, high doses of caffeine may increase anxiety, but
this is rarely seen in normal consumption (Smith, 2002).
The study by Nardi et al. (2007) analyzed in two ways how
panic from the caffeine challenge test manifested in subjects that
suffer from anxiety. The aim of the study was to determine
whether patients with PD experience more caffeine-related symp-
toms or whether they perceive their symptoms more severely than
others.
Nardi et al. (2007) suggest that patients with panic disorder
(PD), when compared to depressive patients, showed increased
sensitivity to the effects of low doses of caffeine. Patients with PD
have an increase in subject-related anxiety, nervousness, fear, nau-
sea, palpitations, and tremors after administration of caffeine. The
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precise mechanism underlying caffeine panicogenic potentials is
uncertain, with the antagonism of adenosine receptors being the
most likely pathway (Nardi et al., 2007). Imaging studies of cere-
bral blood ﬂow using position emission topography indicates a
decrease in panic attacks with caffeine and increase in glucose
utilization (Nardi et al., 2007). However, not all individuals with
PD display increased panic attack frequency with caffeine inges-
tion, suggesting that there might be subgroups of patients with PD
with caffeine-provoked panic being linked to long-lasting anxiety
symptoms lasting hours (Nardi et al., 2007).
HALLUCINATIONS
Caffeine users that consume caffeine approximate to seven cups
of instant coffee (>300mg caffeine) a day are more likely to
report hallucinatory experiences such as seeing things that are
not there and hearing voices, when compared to low-level caffeine
users that consume caffeine equivalent to one to three cups of
coffee a day (Jones and Fernyhough, 2009). Researchers indicate
that the hallucinatory experiences may be due to caffeine inten-
sifying the physiological effects of stress, as cortisol is released
during stressful periods when people have recently taken in caf-
feine (Lovallo et al., 2006), this additional upsurge of cortisol may
link caffeine consumption with a higher tendency to hallucinate
(Jones and Fernyhough, 2009). Caffeine use can lead to caffeine-
intoxication, symptoms of which are nervousness, irritability, anx-
iety, muscle-twitching, insomnia, headaches, palpitations (Jones
and Fernyhough, 2009).
CAFFEINE DEPENDENCE
Ninety-eight percent of North America consumes some form of
caffeine, making it the most widely used drug on that continent
(Jones and Fernyhough, 2009).Many caffeine consumers proclaim
that they are addicted to the substance, however the evidence is
inconsistent. Table 2 lists the DSM-IV Criteria for evaluating sub-
stance dependency (American Psychiatric Association, 2000;Dews
et al., 2002). Users must meet a minimum of three criteria to
be considered dependent on a substance. However, with caffeine,
complications arise in the grading of the criteria as the effects of
caffeine are highly variable across consumers and because the use
of caffeine is socially acceptable. Entire afternoons are planned
around coffee dates and many social rituals revolve around the
drink.
Table 2 |The DSM-IV criteria for evaluating substance dependence
(American Psychiatric Association, 2000; Dews et al., 2002).
1. Tolerance (to the substance)
2. Substance-speciﬁc withdrawal symptoms syndrome
3. Substance taken in larger amount over a longer period
4. Persistent or unsuccessful efforts to cut down or control use (of the
substance)
5. A great deal of time spent in activities necessary on obtaining the
effect, use, and recover from the effects of the substance
6. Importance social, occupational, or recreational activities given up or
reduced due to the substance
7. Use continued despite present or recurring physical or physiological
health problems resulting from use of the substance
Using the DSM criteria it was reported that 11% of 6778
daily caffeine users evaluated proclaimed to experience with-
drawal symptoms (American Psychiatric Association, 2000; Dews
et al., 2002). Controversy arose when the withdrawal symptoms
were reported to be mild to moderately bearable and diminishing
over a short period of time, therefore reducing the intensity of
withdrawal symptoms (Dews et al., 2002; Jones and Fernyhough,
2008). According to Keast and Riddell (2007) only the minority of
the caffeine users are actually dependent on caffeine. The debate
about the possible addictive strength of caffeine remains unsettled,
but caffeine withdrawal has been linked with feelings of fatigue,
increased depression, and anxiety (Smith, 2002).
DISCUSSION
In summary, themost salient effects of caffeine can be summarized
as follows.
Most people consume caffeine to compensate for a lack of
sleep, to complete tiring tasks, or to ease stress. Caffeine prod-
ucts are ubiquitously used for these reasons and more yet, Table 3
indicates that the disadvantages of caffeine are more clearly docu-
mented than the advantages. The health beneﬁts from caffeine are
increased arousal and facilitating against stress in the human body.
These beneﬁts are important in maintaining safety and efﬁcacy in
the workplace and other environments. To derive an increase in
arousal could lead to individuals over consuming caffeine drinks,
this over consumption could then bring about some of the dis-
advantages such as anxiety and panic attacks (when doses more
than 300mg caffeine are ingested) or cause individuals to hal-
lucinate (again when doses more than 300mg are ingested). It
was noted that when individuals are stressed, their caffeine intake
increases and caffeine lead to a sensitization of the cannabinoid
receptors to help alleviate stress. Despite this beneﬁt, it could
create a larger predicament by causing individuals to become
dependent on the substance or exemplifying this by becoming
dependent on other drugs.Morphine,heroin, cocaine, and ethanol
also cause enhancement of the cannabinoid receptors and caffeine
has additive properties (like cocaine). Furthermore it reinforces the
cocaine-seeking behavior strengthening the dependence potential
of caffeine. While caffeine may be used to increase arousal, in
contrast it causes impairment in learning by congesting replay of
memories and impairing motor skills with a moderate dose of
caffeine.
It appears that the most signiﬁcant beneﬁts derived from
caffeine involve increased alertness. Further beneﬁts are gen-
erally only derived from high dosages of caffeine. How-
ever, such doses cause harmful effects on neurophysiological
Table 3 | Summary of some effects of caffeine on humans.
Advantages Disadvantages
Increases arousal (reduces fatigue) Causes anxiety and panic attacks
Aids against stress Leads to hallucination
Caffeine dependence
Abuse of caffeine (energy drinks)
Impairs learning
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Table 4 | Energy drinks in the United States (Reissig et al., 2009).
Top selling energy drinks Total caffeine (mg)
Red Bull* 80
Monster* 160
No fear* 174
Wired X505 505
Fixx 500
SPIKE shooter* 300
Viso energy vigor 300
Cocaine energy drink 280
*Sold in South Africa.
Table 5 | Effects of the energy drink combined with ethanol
administered (Ferreira et al., 2004).
Ethanol dose Effect
Low dose of ethanol Reduced the energy drink stimulant
Moderate dose of ethanol Reduced the energy drink stimulant
High dose of ethanol Reduced the locomotor activity
The energy drink decreased the depressant
effect of ethanol
health, with the exception of the effects on cardiac condi-
tions which are experienced even at low to moderate doses of
caffeine.
One of the most important current caffeine concerns involves
energy drinks. There has been a vast increase in energy drink con-
sumption in young adults aged 18–24 years (Côté, 2009). These
energy drinks are not to be confused with sports drinks as they
contain high amounts of caffeine and taurine and do not hydrate
the body. In 2006Thailand had the leading energy drink consump-
tion per person but the United States reported the highest sales
of energy drinks (Reissig et al., 2009). The energy drink indus-
try has grown exponentially with almost 500 brands launched
internationally in 2006.
The drinks differ rather dramatically in caffeine content (Reis-
sig et al., 2009). From Table 4 it is clear that levels of caffeine
in these drinks are very high. These drinks are sold without age
restrictions and the majority of these drinks do not have a warn-
ing label advising the consumer on the caffeine content and the
potential health risks (Reissig et al., 2009).
Aside from the possible addictive potential of caffeine, caf-
feine intoxication is a recognized syndrome (Reissig et al., 2009).
The high caffeine content in energy drinks increases the risk
for caffeine overdose, so awareness of this is required (Reissig
et al., 2009). Unfortunately though, there is no regulation of
the marketing of energy drinks targeted at the young adults.
This is surprising, given that pharmacological and epidemiolog-
ical studies show an association between caffeine use, depen-
dence on alcohol, nicotine, and drugs such as cocaine, mor-
phine, and heroin because caffeine shares features with these
commonly studied drugs (Reissig et al., 2009; Dack and Reed,
2009).
There is also increased popularization of combined use of alco-
holic beverages and energy drinks. This may seem harmless, given
that some reports suggest that energy drinks could decrease the
intensity of the depressant effects of ethanol (Ferreira et al., 2004).
In the study by Ferreira et al. (2004) ethanol in doses of 0.5, 1.0,
1.5, and 2.5 g/kg was combined with a well-known energy drink
and administered to mice. The results are found in Table 5.
The data obtained suggests that energy drinks did antagonize
the depressant effect of ethanol in the locomotor activity of mice
but only at high does of ethanol. Considering that mice have a
much faster metabolism than humans, the alterations of the lev-
els of locomotor activity in mice cannot simply be interpreted as
a reversion of the symptoms of acute effects of alcohol (Ferreira
et al., 2004). Furthermore, the combination of energy drinks and
alcohol reduces participants’ perceptions of impairment of motor
co-ordination but does not decrease objectivemeasures of alcohol-
induced impairment of motor co-ordination, reaction time, or
breathe alcohol concentration. This may increase the possibility of
alcohol-related injury and motor accidents as the individuals may
feel that the energy drink has antagonized the effects of alcohol
while their co-ordination and judgment are still impaired (Reissig
et al., 2009).
CONCLUSION
The massive popularity of caffeine has created a need to dis-
cover the possible inﬂictions on the human body. By delving into
the biochemical characteristics of caffeine, ﬁndings on its struc-
ture and chemical properties have led to ﬁndings on its function,
absorption in the body and metabolism. The neurophysiological
beneﬁts of caffeine are brief and ironically could lead to health
disadvantages. Therefore in order to obtain the beneﬁts consump-
tion should be limited to moderate doses. The neurophysiological
health disadvantages of caffeine include anxiety and panic attacks
and hallucinations brought about by above moderate doses of
caffeine. In addition to this caffeinemay impair learning andmem-
ory. However, most alarming is the similarity of caffeine to other
drugs such as morphine, heroin, ethanol, and most importantly to
cocaine. Caffeine shows the most similarity to cocaine and rein-
forces cocaine-seeking behavior after elimination of the drug. This
ﬁnding strengthens the argument that the potential of caffeine
dependence is high and awareness of this should be created.
Regarding caffeine in energy drinks, a number of questions
arise out of this review. For example, should such aggressive
marketing be allowed for a substance that serves as a portal to
other forms of drug dependence? With energy drinks decreas-
ing the perceived depressant effects of alcohol individuals may
consume more alcohol and therefore jeopardize their perception
and hence safety. Given the neurophysiological implication of
caffeine use, advertising and marketing of energy drinks and caf-
feinated soft drinks should be considered. Research on caffeine in
South Africa is very limited and considering the potential nega-
tive health impacts of this drug further research to focusing on
the negative health impacts of moderate caffeine consumption
is needed. In the mean time, awareness on its potential health
consequences, caffeine intoxication, withdrawal, and dependence
should be mandatory.
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